MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Return on equity
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to MLTXSource: SEC XBRL filings · For reference only · Not investment advice
More MLTX financial trends
MLTX RevenueMLTX Net incomeMLTX Net marginMLTX Gross profitMLTX Gross marginMLTX Operating incomeMLTX Operating marginMLTX Operating cash flowMLTX Free cash flowMLTX Capital expendituresMLTX Stock buybacksMLTX Dividends paidMLTX Total assetsMLTX Total liabilitiesMLTX Shareholders’ equityMLTX overview →